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Background: 1,8-Naphthyridine derivatives have attracted considerable attention because the 1,8-naphthyridine skeleton
is present in many compounds that have been isolated from natural substances, with various biological activities.
Findings: N,N-dimethoxy-N-methyl-1,8-naphthyridine-3-carboxamide (1) on reaction with Grignard reagent forms
2-methoxy-1,8-naphthyridine-3-carbaldehyde (2). Compound 2 on reaction with different aromatic aldehydes provided
1-(2-cyclopropyl-1,8-naphthyridin-3-yl)-3-arylprop-2-en-1-ones (3a-e) and these compounds on cyclisation with hydrazine
hydrate 99% yielded 2-cyclopropyl-3-(5-aryl-1H-pyrazol-3-yl)-1,8-naphthyridines (4-a-e).
Synthesis of the target compounds involved the formation of 4a-e. It was accomplished using Grignard reaction,
condensation reaction, and cyclisation reactions. All the synthesized compounds were readily soluble in DMSO. Spectral
data of the synthesized compounds were in full agreement with the proposed structures.
Conclusions: In conclusion, we have developed a simple and an efficient Synthesis of 2-cyclopropyl-3-(5-aryl-1H-pyrazol-
3-yl)-1,8-naphthyridine.
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Background
Among the wide variety of heterocycles that have been
explored for developing pharmaceutically important
molecules, such as chalcones, pyrazolines and amino
pyrimidines have played an important role in medicinal
chemistry. The presence of reactive α,β-unsaturated
carbonyl function in chalcones is found to be respon-
sible for their antibacterial and antifungal activity. Nitrogen
containing heterocyclic compounds find extensive pharma-
ceutical applications and possess biologically activity. Many
of the naphthyridines have shown bacterial, fungicidal and
carcinogenic activity [1-3]. As a step in this direction and
in continuation of our work on 1, 8-naphthyridines [4-7],
synthesis of the title compounds was carried out. The
general synthetic procedures used in the preparation of
these compounds involved the cyclisation of Schiff ’s
bases [8-12].* Correspondence: mtcharya@yahoo.com
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reproduction in any medium, provided the origThe structure of the compounds were confirmed on
the basis of their spectral (1H NMR and mass) data. The
synthetic approach is outlined in Scheme 1.
Methods
A simple conventional method is followed to prepare all
the title compounds.
Results and discussion
Compound (1), when reacted with Grignard reagent and
gave 2-methoxy-1,8-naphthyridine-3-carbaldehyde (2)
which was reacted with different aldehydes to form aryli-
dene derivatives (3a-e), which on treatment with hydra-
zine hydrate afforded compound (4a-e).
Experimental
Melting points were determined in open capillaries and
are uncorrected. 1H NMR spectrum is taken on a Varian
500 MHz instrument with TMS as an internal standard.
The chemical shifts are expressed δ ppm, and the solvent
used is DMSO-d6. Mass spectrum is taken on Hewlett-
Packard mass spectrometer operating at 70 eV. All the
compounds are recrystalised from ethanol.is is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Scheme 1 Synthesis of 1,8-naphthyridines.
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To a solution of 2-cyclopropyl-N-methoxy-N-methyl-
1,8-naphthyridine-3-carboxamide (1) (1.01 mmol) in
THF (10 mL), MeMgCl (3.03 mmol) was added drop
wise at −30°C and stirred for about 2 h at −30°C. The
resulting solution is quenched with a saturated NH4Cl
solution (30 mL), filtered, extracted with EtOAc (3 ×
30 mL) and dried over Na2SO4. The resulting crude
compound was purified by a column chromatography
by eluting 20% to 40% ethyl acetate in hexane to obtain
the light yellow colour solid.
1H NMR (DMSO-d6, 500 MHz): δ 1.06-1.21 (m, 4H,
2CH2), 2.24 (s, 3H, CH3), 2.57 (m, 1H, CH), 7.57 (t, 1H, J =
12Hz CH), 8.31 (s, 1H, J = 12Hz CH), 8.42, (d, 1H, CH),
9.02 (d, 1H, J = 10Hz CH). Mass [M+ 1] peak at m/z 213.
1-(2-cyclopropyl-1,8-naphthyridin-3-yl)-3-phenylprop-2-en-1-
one (3a)
To a solution of 1-(2-cyclopropyl-1,8-naphthyridin-3-yl)
ethanone (2) (0.53 mmol) in DMF, NaOH (0.79 mmol)
and aldehyde (0.63 mmol) were added at 0°C and stirred
for about 1 h. Then water was added and extracted with
DCM (2 × 15 mL), dried over Na2SO4 and evaporated
under reduced pressure. The resulting crude compound
was purified by a column chromatography by eluting 20%
to 40% ethyl acetate in hexane to obtain the light yellow
colour solid.
1H NMR (DMSO-d6, 500 MHz): δ 1.12-1.28 (m, 4H,
2CH2), 2.61 (m, 1H, CH), 7.62 (m, 2H, J = 14Hz 2CH), 7.81
(dd, 2H, J = 18Hz 2CH), 8.23, (m, 3H, 3CH), 8.51-8.61 (m,
4H, J = 18Hz 4CH), 9.12 (s, 1H, CH). Mass [M+ 1] peak at
m/z 301.
Other compounds in the series were prepared similarly
and their characterization data are recorded below.
3-(4-bromophenyl)-1-(2-cyclopropyl-1,8-naphthyridin-3-yl)
prop-2-en-1-one (3b)
1H NMR (DMSO-d6, 500 MHz): δ 1.14-1.29 (m, 4H,
2CH2), 2.52,(m, 1H, CH), 7.62 (m, 4H, 4CH), 7.71 (d,
2H, J = 12Hz 2CH), 8.23, (d, 1H, 1CH), 8.69 (s, 1H,
1CH), 9.22 (s, 1H, CH).Mass [M + 1] m/z 380.
1-(2-cyclopropyl-1,8-naphthyridin-3-yl)-3-(4-methoxyphenyl)
prop-2-en-1-one (3c)
1H NMR (DMSO-d6, 500 MHz): δ 1.16-1.27 (m, 4H,
2CH2), 2.48 (m, 1H, CH), 7.62 (m, 4H, 4CH), 7.69 (d,2H, J = 12Hz 2CH), 8.33 (d, 1H, , J = 12Hz, 1CH), 8.71 (s,
1H, 1CH), 9.24 (s, 1H, CH). Mass [M+ 1] peak at m/z 331.
1-(2-cyclopropyl-1,8-naphthyridin-3-yl)-3-p-tolylprop-2-en-1-
one (3d)
1H NMR (DMSO-d6, 500 MHz): δ 1.19-1.28 (m, 4H,
2CH2), 2.53 (m, 1H, CH), 7.63 (m, 4H, 4CH), 7.72 (d, 2H,
J = 14Hz 2CH), 8.42 (d, 1H, J = 14Hz, 1CH), 8.78 (s, 1H,
1CH), 9.28 (s, 1H, CH).Mass [M + 1] peak at m/z 315.1-(2-cyclopropyl-1,8-naphthyridin-3-yl)-3-(4-nitrophenyl)
prop-2-en-1-one (3e)
1H NMR (DMSO-d6, 500 MHz): δ 1.23-1.31 (m, 4H,
2CH2), 2.62 (m, 1H, CH), 7.73 (m, 4H, 4CH), 7.81 (d, 2H,
J = 18Hz 2CH), 8.56 (d, 1H, J = 16Hz, 1CH), 8.64 (s, 1H,
1CH), 9.32 (s, 1H, CH).Mass [M + 1] peak at m/z 346.2-cyclopropyl-3-(5-phenyl-1H-pyrazol-3-yl)-1,8-
naphthyridine (4a)
To a solution of 1-(2-cyclopropyl-1,8-naphthyridin-3-yl)-
3-phenylprop-2-en-1-one (3a) (0.31 mmol) in ethanol
(5 mL), hydrazine hydrate 99%(2 mL) was added. The
resulting solution was refluxed for about 12 h. After
completion of a starting material, the ethanol was evapo-
rated completely under a reduced pressure then the title
compound was recrystalised from diethyl ether to obtain
the brown colour solid.
1H NMR (DMSO-d6, 500 MHz): δ 1.16(m, 2H, CH2),
1.22 (m, 2H, CH2), 2.21 (m, 1H, CH), 5.21(s, 1H, J = 12Hz
CH), 5.41(s, 1H, J = 12Hz CH), 6.31 (m, 1H, J = 12Hz CH),
6.59, (m, 2H, 2CH), 7.19 (d, 1H, J = 10Hz CH), 7.69 (m,
4H, 4CH), 8.42 (m, 2H, 2CH), 9.11 (s, 1H, CH), 10.81 (s,
1H, NH). Mass [M+ 1] peak at m/z 313.
Other compounds in the series were prepared similarly
and their characterization data are recorded below.3-(5-(4-bromophenyl)-1H-pyrazol-3-yl)-2-cyclopropyl-1,8-
naphthyridine (4b)
1H NMR (DMSO-d6, 500 MHz): δ 1.21(m, 2H, CH2),
1.28 (m, 2H, CH2), 2.37 (m, 1H, CH), 6.21 (s, 1H, J =
12Hz CH), 7.32(s, 1H, CH), 7.41 (m, 4H, J = 12Hz 4CH),
8.19 (m, 2H, 2CH), 8.39 (d, 1H, CH), 10.69 (s, 1H, NH).
Mass [M + 2] peak at m/z 392.
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naphthyridine (4c)
1H NMR (DMSO-d6, 500 MHz): δ 1.24 (m, 2H, CH2),
1.29 (m, 2H, CH2), 2.28 (m, 1H, CH), 4.12 (s, 3H, CH3),
6.23 (s, 1H, CH), 7.35 (s, 1H, CH), 7.29 (m, 4H, J = 12Hz
4CH), 8.03, (m, 2H, 2CH), 8.42 (d, 1H, CH), 10.46 (s, 1H,
NH). Mass [M+ 1] peak at m/z 343.
2-cyclopropyl-3-(5-p-tolyl-1H-pyrazol-3-yl)-1,8-naphthyridine
(4d)
1H NMR (DMSO-d6, 500 MHz): δ 1.18 (m, 2H, CH2),
1.31 (m, 2H, CH2), 2.20 (m, 1H, CH), 2.39 (s, 3H, CH3),
6.28 (s, 1H, CH), 7.25 (s, 1H, CH), 7.39 (m, 4H, 4CH), 8.23,
(m, 2H, 2CH), 8.44 (d, 1H, J = 12Hz, CH), 10.59 (s, 1H,
NH). Mass [M+ 1] peak at m/z 327.
2-cyclopropyl-3-(5-(4-nitrophenyl)-1H-pyrazol-3-yl)-1,8-
naphthyridine (4e)
1H NMR (DMSO-d6, 500 MHz): δ 1.18 (m, 2H, CH2), 1.31
(m, 2H, CH2), 2.20 (m, 1H, CH), 6.18 (s, 1H, CH), 7.15 (s,
1H, CH), 7.27 (m, 4H, 4CH), 8.12, (m, 2H, 2CH), 8.24 (d,
1H, J = 12Hz, CH), 11.19 (s, 1H, NH). Mass [M+ 1] peak at
m/z 358.
Conclusions
We have presented simple, cost effective, and practical
method for preparation of some 1,8-naphthyridines.
This methodology provides an efficient alternative to
existing methods for the synthesis of 2-cyclopropyl-3-(5-
aryl-1H-pyrazol-3-yl)-1,8-naphthyridine. Here in step-1, we
observed the formation of Grignard product which on con-
densation of aldehydes Schiff's base is formed. Further reac-
tion Schiff's base with hydrazine we obtained the pyrazoles.
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